2,076 results on '"Raman, Jay"'
Search Results
2. MP17-04 TRENDS IN CHIEF RESIDENT CASE LOGS VERSUS SUBSEQUENT CASE LOG DATA IN CLINICAL PRACTICE
3. Practice Readiness? Trends in Chief Resident Year Training Experience Across 13 Residency Programs
4. Model risk scores may underestimate rate of biochemical recurrence in African American men with localized prostate cancer: a cohort analysis of over 3000 men
5. Current Perceptions, Practice Patterns, and Barriers to Adoption of Transperineal Prostate Biopsy Under Local Anesthesia
6. Clinicopathological risk factors associated with tumor relapse of upper tract urothelial carcinoma after radical nephroureterectomy: A single institution 20-year experience
7. Complications and Surgeon Health: Resources for individuals and institutions
8. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features
9. Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial.
10. Gender-based Disparity Exists in the Surgical Experience of Female and Male Urology Residents
11. Getting It Across the Finish Line: Publication Rates of Abstracts Presented at a Major Urologic Conference
12. Urology Match: Important Factors Women Consider When Choosing a Residency Training Program
13. Contemporary Patients Have Better Perioperative Outcomes Following Cytoreductive Nephrectomy: A Multi-institutional Analysis of 1272 Consecutive Patients
14. Longitudinal Changes in the Operative Experience for Junior Urology Residents
15. What can urology learn about sponsorship from business and medicine?
16. Management of Residual or Recurrent Disease Following Thermal Ablation of Renal Cortical Tumors.
17. Multiparametric MRI is not sufficient for prostate cancer staging: A single institutional experience validated by a multi-institutional regional collaborative
18. Reply by Authors
19. PD20-07 ONCOLOGIC OUTCOMES IN PATIENTS WITH VARIANT HISTOLOGIES OF UPPER TRACT UROTHELIAL CANCER: RESULTS FROM AN INTERNATIONAL MULTICENTER COHORT
20. PD08-08 A MULTICENTER PROSPECTIVE RANDOMIZED CONTROLLED TRIAL COMPARING CXBLADDER TRIAGE TO CYSTOSCOPY IN PATIENTS WITH MICROHEMATURIA
21. PD23-05 UNDERSTANDING THE UNDERUTILIZATION OF GENETIC EVALUATION IN PATIENTS WITH PHEOCHROMOCYTOMA AND PARAGANGLIOMA
22. PD18-04 SURVIVAL IS DRAMATICALLY IMPROVED FOR MRCC PATIENTS WITH SARCOMATOID FEATURES WHO ARE TREATED WITH CYTOREDUCTIVE NEPHRECTOMY AND IMMUNE CHECKPOINT INHIBITORS REGARDLESS OF TREATMENT SEQUENCE
23. MP39-21 ASSOCIATION BETWEEN RESIDENT IN SERVICE EXAM SCORES BY POST-GRADUATE YEAR AND BOARD QUALIFYING EXAM
24. MP02-18 APPROPRIATENESS OF IMAGING FOR LOW-RISK PROSTATE CANCER – REAL WORLD DATA FROM THE PENNSYLVANIA UROLOGIC REGIONAL COLLABORATION (PURC)
25. MP71-17 10-YEAR TRENDS IN PERIOPERATIVE OUTCOMES IN BLADDER CANCER PATIENTS UNDERGOING RADICAL CYSTECTOMY WITH ILEAL CONDUIT URINARY DIVERSION
26. PD18-06 VALIDATION OF THE SELECTION FOR CYTOREDUCTIVE NEPHRECTOMY (SCREEN) MODEL USING AN INDEPENDENT CONTEMPORARY MULTI-CENTER COHORT
27. MP38-02 PATTERNS OF NON-UROTHELIAL RECURRENCE AFTER NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA (UCAN COLLABORATION)
28. PD20-08 RESPONSE TO NEOADJUVANT CHEMOTHERAPY IS ASSOCIATED WITH IMPROVED SURVIVAL IN UPPER TRACT UROTHELIAL CARCINOMA—AN UPPER TRACT COLLABORATIVE NETWORK (UCAN) STUDY
29. Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study
30. Bladder Chemoprophylaxis Following Ureterorenoscopy in Patients with Upper Tract Urothelial Carcinoma
31. Non-infectious complications following transrectal prostate needle biopsy – Outcomes from over 8000 procedures
32. A transcriptional network of cell cycle dysregulation in noninvasive papillary urothelial carcinoma
33. Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
34. FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
35. Bladder Cancer: Overview, Epidemiology, Initial Presentation and Diagnosis
36. Appropriateness of Imaging for Low-Risk Prostate Cancer—Real World Data from the Pennsylvania Urologic Regional Collaboration (PURC).
37. Prior Negative Biopsy, PSA Density, and Anatomic Location Impact Cancer Detection Rate of MRI-Targeted PI-RADS Index Lesions.
38. Significant Bleeding Complications Following Transrectal Prostate Needle Biopsy: Incidence, Predictors, and Management
39. Topical antiseptic at time of transrectal ultrasound prostate biopsy is associated with fewer severe clinical infections and improves antibiotic stewardship
40. RACIAL EQUITY IN ACTIVE SURVEILLANCE UTILIZATION OF LOW- AND INTERMEDIATE-RISK MEN WITHIN THE PENNSYLVANIA UROLOGIC REGIONAL COLLABORATIVE (PURC)
41. Utilization of Patient-Specific Characteristics and Competing Risks to Tailor the Duration of Surveillance Imaging After Surgery for Renal Cell Carcinoma
42. DEFINING THE IMPACT OF PERSONAL AND FAMILY HISTORY OF LYNCH-SYNDROME ASSOCIATED CANCERS ON CLINICAL CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA
43. DISPARITIES IN UTILIZATION OF GENETIC EVALUATION IN PATIENTS WITH KIDNEY CANCER WHO MEET GUIDELINES FOR GENETIC REFERRAL
44. ONCOLOGIC OUTCOMES OF GEMCITABINE-DOCETAXEL COMBINATION INTRAVESICAL BLADDER SPARING THERAPY COMPARED TO UPFRONT RADICAL CYSTECTOMY IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
45. NATURAL HISTORY OF BLADDER-SPARING THERAPY IN PATIENTS WITH BCG-UNRESPONSIVE DISEASE; RESULTS FROM A LARGE MULTI-CENTER COHORT
46. Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy
47. Engaging disparities in prostate cancer: Piloting an interactive, virtual workshop to educate providers on shared decision-making for underserved populations
48. Impact of the evolving United States Preventative Services Task Force policy statements on incidence and distribution of prostate cancer over 15 years in a statewide cancer registry
49. Can preoperative imaging characteristics predict pT3 bladder cancer following cystectomy?
50. Adherent perinephric fat affects perioperative outcomes after partial nephrectomy: a systematic review and meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.